The UK is not going to change the Gender Recognition Act! 

The tide of gender ideology may just have broken. Finally some good news for women. Now in Canada we have to get after Bill C-16 and get it changed stat, because both gender and sex cannot be protected characteristics under the law.

“The law on women-only spaces also needs clarity. Some of this will take time — you can’t grow healthcare and support capacity overnight, but I think all sides of the debate will be reassured when the consultation results are published.”

At present NHS rules enable children to start gender transition treatment before puberty without their parents’ support. Children unhappy with their birth gender can begin treatment after as few as three therapeutic assessments. They can discuss treatments separately from their parents and are encouraged to self-define their status and to develop “autonomy” in decision-making. Interventions include hormone blockers to suppress puberty and, later, cross-sex hormone therapy. The average age at which children begin such treatments is 14, but some are as young as 12.

NHS England has ordered an independent review into the use of puberty suppressant drugs and cross-sex hormones. The National Institute for Health and Clinical Excellence (Nice), which is responsible for clinical practice guidelines in England and Wales, has also been asked to develop guidance for the first time about referring children to gender identity services.

Existing NHS treatment draws heavily on international guidelines that recommend approaches in care for gender dysphoria.

An NHS contract with the Tavistock & Portman Trust, issued in 2016, says that it will “conform” or “broadly conform” to standards of care issued by the World Professional Association for Transgender Health (WPATH) in 2012. These say that they reflect the best available science and “professional consensus”. The Tavistock Trust works with children and young people with gender identity issues.

However, Gene Feder, professor of primary care at the University of Bristol and an expert in clinical guidelines, said that these fell far below the benchmark for British healthcare guidelines used by Nice and that he would not recommend their use.”